The MOSPD2 Knockout Raji Polyclonal Cells product is a CRISPR/Cas9-edited polyclonal knockout cell population derived from the Raji B lymphocyte line. This pool contains a heterogeneous array of MOSPD2 gene disruptions, creating a loss-of-function model free from clonal bias. It is designed for population-level functional studies where the collective impact of gene knockout is assessed, offering a robust system for genotype-phenotype analyses in lymphoblastoid cells.
The Raji cell line is a human B lymphocyte model originating from a Burkitt lymphoma patient and maintains an EBV-positive, suspension growth phenotype. Widely used in B cell biology, lymphomagenesis research, and immunological assays, Raji cells provide a well-characterized background with active signaling pathways and rapid proliferation, making them amenable to genetic manipulation and downstream functional profiling.
MOSPD2 encodes a membrane protein featuring a major sperm protein (MSP) domain, a motif linked to cytoskeletal dynamics and cell motility in other systems. Although the precise function of MOSPD2 remains undetermined, its MSP domain suggests potential roles in actin remodeling, membrane protrusion, and signal transduction. In the B cell context, MOSPD2 may engage with cytoskeletal regulatory elements, thereby influencing processes such as migration, adhesion, and immune synapse assembly, but its interacting partners are currently unknown.
Knocking out MOSPD2 in Raji cells provides a tractable model to investigate the contribution of MSP domain proteins to lymphocyte biology. B lymphocytes rely on dynamic cytoskeletal reorganization for chemotaxis, antigen presentation, and cell?Ccell interactions; disruption of MOSPD2 could therefore impair these functions and illuminate pathways relevant to lymphomagenesis. The polyclonal nature of the knockout population captures diverse editing events, enabling the detection of phenotypic heterogeneity that may be critical for understanding MOSPD2??s role.
This product supports a variety of experimental applications. Knockout validation can be performed by Western blotting and RT-qPCR. Functional consequences on cell motility are assessable using transwell migration and invasion assays, while flow cytometry facilitates phenotypic profiling of surface antigens and viability. Co-immunoprecipitation coupled with mass spectrometry may uncover novel protein?Cprotein interactions, and RNA-seq can reveal transcriptome-wide changes. These tools make the MOSPD2 knockout Raji polyclonal cells a valuable resource for functional genomics and MSP domain research. For inquiries, please contact Ascent Research.
